- Home
- KALA vs ASPS Comparison
KALA vs ASPS Comparison
Compare KALA & ASPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- ASPS
- Stock Information
- Founded
- KALA 2009
- ASPS 1999
- Country
- KALA United States
- ASPS Luxembourg
- Employees
- KALA N/A
- ASPS N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- ASPS Other Consumer Services
- Sector
- KALA Health Care
- ASPS Consumer Discretionary
- Exchange
- KALA Nasdaq
- ASPS Nasdaq
- Market Cap
- KALA 27.3M
- ASPS 22.8M
- IPO Year
- KALA 2017
- ASPS N/A
- Fundamental
- Price
- KALA $6.64
- ASPS $0.71
- Analyst Decision
- KALA Strong Buy
- ASPS
- Analyst Count
- KALA 2
- ASPS 0
- Target Price
- KALA $15.00
- ASPS N/A
- AVG Volume (30 Days)
- KALA 108.1K
- ASPS 157.1K
- Earning Date
- KALA 03-28-2025
- ASPS 03-06-2025
- Dividend Yield
- KALA N/A
- ASPS N/A
- EPS Growth
- KALA N/A
- ASPS N/A
- EPS
- KALA N/A
- ASPS N/A
- Revenue
- KALA N/A
- ASPS $153,278,000.00
- Revenue This Year
- KALA N/A
- ASPS $14.04
- Revenue Next Year
- KALA N/A
- ASPS $33.86
- P/E Ratio
- KALA N/A
- ASPS N/A
- Revenue Growth
- KALA N/A
- ASPS 5.19
- 52 Week Low
- KALA $4.21
- ASPS $0.43
- 52 Week High
- KALA $11.20
- ASPS $3.17
- Technical
- Relative Strength Index (RSI)
- KALA 39.29
- ASPS 45.14
- Support Level
- KALA $6.50
- ASPS $0.74
- Resistance Level
- KALA $8.65
- ASPS $0.84
- Average True Range (ATR)
- KALA 0.90
- ASPS 0.13
- MACD
- KALA -0.43
- ASPS -0.02
- Stochastic Oscillator
- KALA 2.98
- ASPS 12.63
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About ASPS Altisource Portfolio Solutions S.A.
Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments namely Servicer and Real Estate and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource primarily serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of revenue flowing from field services and mortgage and real estate solutions.